Bactiquant (Denmark) Performance
| BACTIQ Stock | DKK 3.80 0.24 5.94% |
The firm shows a Beta (market volatility) of -0.0921, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bactiquant are expected to decrease at a much lower rate. During the bear market, Bactiquant is likely to outperform the market. At this point, Bactiquant AS has a negative expected return of -0.59%. Please make sure to confirm Bactiquant's standard deviation, kurtosis, period momentum indicator, as well as the relationship between the maximum drawdown and day median price , to decide if Bactiquant AS performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bactiquant AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 668.5 K | |
| Free Cash Flow | -15.4 M |
Bactiquant |
Bactiquant Relative Risk vs. Return Landscape
If you would invest 610.00 in Bactiquant AS on August 29, 2024 and sell it today you would lose (230.00) from holding Bactiquant AS or give up 37.7% of portfolio value over 90 days. Bactiquant AS is generating negative expected returns and assumes 5.2803% volatility on return distribution over the 90 days horizon. Simply put, 47% of stocks are less volatile than Bactiquant, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bactiquant Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bactiquant's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bactiquant AS, and traders can use it to determine the average amount a Bactiquant's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1124
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BACTIQ |
Estimated Market Risk
| 5.28 actual daily | 47 53% of assets are more volatile |
Expected Return
| -0.59 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bactiquant is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bactiquant by adding Bactiquant to a well-diversified portfolio.
Bactiquant Fundamentals Growth
Bactiquant Stock prices reflect investors' perceptions of the future prospects and financial health of Bactiquant, and Bactiquant fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bactiquant Stock performance.
| Current Valuation | 137.43 M | |||
| Shares Outstanding | 19.58 M | |||
| Price To Book | 9.57 X | |||
| Price To Sales | 14.05 X | |||
| Revenue | 8.36 M | |||
| EBITDA | (12.34 M) | |||
| Total Debt | 1.04 M | |||
| Cash Flow From Operations | (13.25 M) | |||
| Total Asset | 24.52 M | |||
About Bactiquant Performance
By analyzing Bactiquant's fundamental ratios, stakeholders can gain valuable insights into Bactiquant's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bactiquant has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bactiquant has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bactiquant AS develops and provides technology for the mobile and online surveillance of bacterial contamination levels in water. The company is based in 1998 and is based in Horsholm, Denmark. BactiQuant is traded on Copenhagen Stock Exchange in Denmark.Things to note about Bactiquant AS performance evaluation
Checking the ongoing alerts about Bactiquant for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bactiquant AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bactiquant AS generated a negative expected return over the last 90 days | |
| Bactiquant AS has high historical volatility and very poor performance | |
| The company reported the revenue of 8.36 M. Net Loss for the year was (13.55 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bactiquant generates negative cash flow from operations |
- Analyzing Bactiquant's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bactiquant's stock is overvalued or undervalued compared to its peers.
- Examining Bactiquant's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bactiquant's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bactiquant's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bactiquant's stock. These opinions can provide insight into Bactiquant's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bactiquant Stock analysis
When running Bactiquant's price analysis, check to measure Bactiquant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bactiquant is operating at the current time. Most of Bactiquant's value examination focuses on studying past and present price action to predict the probability of Bactiquant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bactiquant's price. Additionally, you may evaluate how the addition of Bactiquant to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |